| Mr Charles Ellsworth Thompson Iii, RPH | |
|
4396 Highway 24, Anderson, SC 29626-5212 | |
| (864) 226-2398 | |
| (864) 375-0179 |
| Full Name | Mr Charles Ellsworth Thompson Iii |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 4396 Highway 24, Anderson, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306145180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 010629 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Charles Ellsworth Thompson Iii, RPH 4396 Highway 24, Anderson, SC 29626-5212 Ph: (864) 226-2398 | Mr Charles Ellsworth Thompson Iii, RPH 4396 Highway 24, Anderson, SC 29626-5212 Ph: (864) 226-2398 |
News Archive
The last phase of ANRS IPERGAY has confirmed that "on-demand" pre-exposure prophylaxis (PrEP) is a highly effective method of reducing the risk of HIV infection in men who have sex with men and who report high-risk behavior.
A newly conservative Supreme Court agreed to hear a case most assumed it would use to overrule the 1973 landmark abortion-rights ruling, Roe v. Wade. And Democrats on Capitol Hill, convinced the issue would play to their political favor, vowed to bring up legislation that would write abortion protections into federal law.
Researchers from the Sanders-Brown Center on Aging at the University of Kentucky have been able to confirm anecdotal information on patients with both Alzheimer's disease (AD) and cerebrovascular disease (CVD) using mouse models in two different studies.
Alcohol advertisements on social media sites such as Facebook can increase young adults' desire to drink if the ads contain pro-drinking comments from users. That's according to new research in the current issue of the Journal of Studies on Alcohol and Drugs.
OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.
› Verified 5 days ago
Dr. Jennifer E Thompson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-1598 | |
Michael Earl Mcwhorter, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1405 E Greenville St, Anderson, SC 29621 Phone: 864-224-8797 Fax: 864-224-4996 | |
Charles Clinkscales, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 118 Parkside Dr, Anderson, SC 29621 Phone: 864-353-3198 | |
Paul Wilbur Fulbright Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2814 N. Main St, Anderson, SC 29621 Phone: 864-224-3562 | |
Ms. Marla Winstead Kinkle, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1704 E Greenville St, Anderson, SC 29621 Phone: 864-375-9401 Fax: 864-231-9358 | |
Walter Carr, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-2919 | |
Dr. Elizabeth Morash, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109 Essex Dr, Anderson, SC 29621 Phone: 864-512-3428 Fax: 864-512-2093 |